Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 44.05% is in line with its 5-year average of 42.54%, near the high end of its 5-year range (30.81%–47.07%).
1.26% below its 12-month average of 44.61%.
Reported quarterly gross margin; no daily interpolation. Q3 FY2026 (2026-06-30): 44.89%.
GROSS MARGIN
44.05%
GROSS MARGIN AVG TTM
44.61%
GROSS MARGIN AVG 3Y
44.62%
GROSS MARGIN AVG 5Y
42.54%
GROSS MARGIN AVG 10Y
39.72%
GROSS MARGIN AVG 15Y
37.73%
GROSS MARGIN AVG 20Y
36.09%
CURRENT VS TTM AVG
-1.26%
CURRENT VS 3Y AVG
-1.27%
CURRENT VS 5Y AVG
+3.54%
CURRENT VS 10Y AVG
+10.92%
CURRENT VS 15Y AVG
+16.74%
CURRENT VS 20Y AVG
+22.06%
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+6.45%
vs the sector median at left
Market Cap
$1.81B
Gross Margin
72.90%
TTM Avg
70.08%
3Y Avg
67.68%
5Y Avg
66.96%
Market Cap
$1.83B
Gross Margin
58.56%
TTM Avg
71.56%
3Y Avg
79.01%
5Y Avg
81.74%
Market Cap
$1.83B
Gross Margin
9.22%
TTM Avg
11.32%
3Y Avg
13.89%
5Y Avg
14.07%
Market Cap
$1.84B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
22.32%
5Y Avg
30.29%
Market Cap
$1.77B
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Azenta, Inc. (AZTA) | $1.81B | 44.05% | 44.61% | 44.62% | 42.54% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.81B | 72.90% | 70.08% | 67.68% | 66.96% |
| Xencor, Inc. (XNCR)vs › | $1.81B | 91.63% | -7.22% | 16.08% | 9.32% |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.83B | 58.56% | 71.56% | 79.01% | 81.74% |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 9.22% | 11.32% | 13.89% | 14.07% |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.84B | 0.00% | 0.00% | 22.32% | 30.29% |
| Immunome, Inc. (IMNM)vs › | $1.85B | 57.43% | 78.72% | 64.36% | 42.91% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.77B | 100.00% | 100.00% | 100.00% | 100.00% |
| Novavax, Inc. (NVAX)vs › | $1.86B | 93.67% | 81.97% | 61.43% | 74.28% |
| Trevi Therapeutics, Inc. (TRVI)vs › | $1.87B | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
44.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 44.89% |
| 2026-03-31 | 42.84% |
| 2025-12-31 | 42.86% |
| 2025-09-30 | 45.40% |
| 2025-06-30 | 47.07% |
| 2025-03-31 | 45.94% |
| 2024-12-31 | 46.68% |
| 2024-09-30 | 45.47% |
| 2024-06-30 | 45.38% |
| 2024-03-31 | 44.49% |
| 2023-12-31 | 39.78% |
| 2023-09-30 | 35.13% |
| 2023-06-30 | 36.45% |
| 2023-03-31 | 30.81% |
| 2022-12-31 | 37.28% |
| 2022-09-30 | 37.23% |
| 2022-06-30 | 40.57% |
| 2022-03-31 | 44.51% |
| 2021-12-31 | 43.52% |
| 2021-09-30 | 42.72% |
| 2021-06-30 | 42.63% |
| 2021-03-31 | 39.02% |
| 2020-12-31 | 42.69% |
| 2020-09-30 | 42.29% |
| 2020-06-30 | 38.79% |
| 2020-03-31 | 37.54% |
| 2019-12-31 | 36.62% |
| 2019-09-30 | 37.20% |
| 2019-06-30 | 37.93% |
| 2019-03-31 | 37.25% |
| 2018-12-31 | 36.97% |
| 2018-09-30 | 36.07% |
| 2018-06-30 | 35.82% |
| 2018-03-31 | 36.80% |
| 2017-12-31 | 34.83% |
| 2017-09-30 | 38.53% |
| 2017-06-30 | 37.58% |
| 2017-03-31 | 36.16% |
| 2016-12-31 | 33.68% |
| 2016-09-30 | 34.19% |
| 2016-06-30 | 36.71% |
| 2016-03-31 | 34.59% |
| 2015-12-31 | 33.81% |
| 2015-09-30 | 36.23% |
| 2015-06-30 | 35.33% |
| 2015-03-31 | 33.04% |
| 2014-12-31 | 31.85% |
| 2014-09-30 | 33.79% |
| 2014-06-30 | 34.72% |
| 2014-03-31 | 35.19% |
| 2013-12-31 | 35.84% |
| 2013-09-30 | 34.28% |
| 2013-06-30 | 33.61% |
| 2013-03-31 | 31.39% |
| 2012-12-31 | 29.75% |
| 2012-09-30 | 32.32% |
| 2012-06-30 | 32.93% |
| 2012-03-31 | 34.65% |
| 2011-12-31 | 33.57% |
| 2011-09-30 | 35.94% |
| 2011-06-30 | 30.61% |
| 2011-03-31 | 32.01% |
| 2010-12-31 | 32.14% |
| 2010-09-30 | 30.39% |
| 2010-06-30 | 29.28% |
| 2010-03-31 | 26.25% |
| 2009-12-31 | 24.71% |
| 2009-09-30 | 18.51% |
| 2009-06-30 | 8.09% |
| 2009-03-31 | -74.52% |
| 2008-12-31 | 8.70% |
| 2008-09-30 | 21.60% |
| 2008-06-30 | 23.27% |
| 2008-03-31 | 24.68% |
| 2007-12-31 | 26.01% |
| 2007-09-30 | 24.02% |
| 2007-06-30 | 30.16% |
| 2007-03-31 | 32.06% |
| 2006-12-31 | 31.19% |
| 2006-09-30 | 36.43% |
| 2006-06-30 | 38.39% |
| 2006-03-31 | 35.31% |
| 2005-12-31 | 29.04% |
| 2005-09-30 | 35.62% |
| 2005-06-30 | 35.24% |
| 2005-03-31 | 33.65% |
| 2004-12-31 | 35.38% |
| 2004-09-30 | 39.82% |
| 2004-06-30 | 37.27% |
| 2004-03-31 | 36.90% |
| 2003-12-31 | 36.64% |
| 2003-09-30 | 33.09% |
| 2003-06-30 | 32.83% |
| 2003-03-31 | 26.52% |
| 2002-12-31 | 28.72% |
| 2002-09-30 | 16.16% |